The Market Analysis of Global Precision Medical Solution

    According to the "Research Report on Strategic Investigation and Investment Strategy of China Cancer Hospital from 2017 to 2022" issued by Chi Yan Consulting, it shows that in the cancer medical service market, according to statistics, there are about 7.5 million cancer patients in China, accounting for an annual per capita annual expenditure 70,000 yuan, cancer treatment penetration rate of 60%, China's cancer medical services market is about 320 billion yuan.

    In terms of medical resources for cancer treatment, the compound annual growth rate of the hospital beds in the oncology departments of Chinese medical institutions was 10.72% between 2008 and 2014, while that of medical departments in the oncology department of the medical institutions was 15.88% Growth is far less than the growth in patient demand.

         "At present, there are 4.2 million new cases of cancer each year in China and more than 3 million deaths a year. The average five-year survival rate of cancer patients in China is 37%, that in the United States is 67% and that in Japan is 72%." Fu Gang said: The five-year survival rate of tumor patients in China is far lower than that of other countries for two main reasons: First, the medical examination system is underdeveloped and was found later. 50% of cancer patients in China have been admitted to advanced stage, and the United States has only 10 % Of hospitalized patients are advanced patients; second, because the overall treatment norms in China is not very high nationwide.

    According to statistics released by the National Bureau of Statistics, the proportion of deaths caused by malignancies ranked first in the country. In 2015, the number of deaths from cancer was 49.66% of the total deaths. In 2014, this figure was 49.19%.

         It is understood that in the field of cancer treatment, the FDA approved the tumor has more than 80 kinds of targeted drugs. But there are tens of millions of possibilities between these mutations and drugs, which can not be done by manual calculations and can not guarantee 100% accuracy. Through cognitive computing, patients can be gene mutations as the core analysis of all the listed bulk drugs, to seek accurate medical solutions.

Data show that the current precision medical market size has exceeded 60 billion US dollars, of which about 10 billion US dollars precision diagnosis, precision treatment area of 50 billion US dollars. The next five years, the global precision medical market size, will also be 15% annual growth rate, the domestic growth rate will exceed 20%. It is estimated that by 2030, the relevant market size is expected to exceed the one trillion yuan mark.

         In fact, as early as March 2015, the Ministry of Science and Technology held the first expert meeting on precision medical strategies in China and proposed China's accurate medical plan. A year later, the Ministry of Science and Technology announced the implementation of five years of "precision medicine Research "key special guidelines, China's national strategic deployment of precision medical treatment will soon begin to implement. Data show that the state plans to invest 60 billion yuan in China's precision medical plan by 2030.